Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jérémie Nsengimana.

Newcastle AuthorsTitleYearFull text
Dr Jérémie Nsengimana
Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients2022
Dr Jérémie Nsengimana
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity2022
Dr Jérémie Nsengimana
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation2021
Dr Jérémie Nsengimana
Identification of 22 susceptibility loci associated with testicular germ cell tumors2021
Dr Jérémie Nsengimana
Inherited duplications of PPP2R3B predispose to nevi and melanoma via C21orf91-driven proliferative phenotype2021
Dr Jérémie Nsengimana
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cell to targeted therapy2021
Dr Jérémie Nsengimana
ROR2 has a protective role in melanoma by inhibiting Akt activity, cell cycle progression and proliferation2021
Dr Jérémie Nsengimana
SFPQ promotes an oncogenic transcriptomic state in melanoma2021
Dr Jérémie Nsengimana
The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma2021
Dr Jérémie Nsengimana
Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression2021
Dr Jérémie Nsengimana
Tumour gene expression signature in primary melanoma predicts long-term outcomes2021
Dr Helen Close
Dr Jérémie Nsengimana
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma2020
Dr Jérémie Nsengimana
Factors affecting sentinel node metastasis in thin cutaneous melanomas: development and external validation of a predictive nomogram2020
Dr Jérémie Nsengimana
Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchimal transition and metastasis2020
Dr Jérémie Nsengimana
MX 2 is a novel regulator of cell cycle in melanoma cells2020
Dr Jérémie Nsengimana
Study of the female sex survival advantage in melanoma- a focus on X-linked epigenetic regulators and immune responses in two cohorts2020
Dr Jérémie Nsengimana
Batool Shannan
Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma2019
Dr Jérémie Nsengimana
Genetic and environmental determinants of immune response to cutaneous melanoma2019
Dr Jérémie Nsengimana
High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material2019
Dr Jérémie Nsengimana
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma2019
Dr Jérémie Nsengimana
Vitamin D–VDR signaling inhibits Wnt/b-catenin–mediated melanoma progression and promotes antitumor immunity2019
Dr Jérémie Nsengimana
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis2018
Dr Jérémie Nsengimana
Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene2018
Dr Jérémie Nsengimana
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas2018
Dr Jérémie Nsengimana
A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination2017
Dr Jérémie Nsengimana
Design considerations for genetic linkage and association studies2017
Dr Jérémie Nsengimana
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF1482017
Dr Jérémie Nsengimana
Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis2017
Dr Jérémie Nsengimana
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor2017
Dr Jérémie Nsengimana
Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach2017
Dr Jérémie Nsengimana
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities2016
Amy Lloyd
Dr Jérémie Nsengimana
Identification of four new susceptibility loci for testicular germ cell tumour2015
Dr Jérémie Nsengimana
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort2015
Dr Jérémie Nsengimana
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q252015
Dr Jérémie Nsengimana
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma2015
Dr Jérémie Nsengimana
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma2015
Dr Jérémie Nsengimana
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer2014
Dr Jérémie Nsengimana
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy2014
Dr Jérémie Nsengimana
Renin–angiotensin system genes and coronary artery calcification2007